Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

1,722.00p
   
  • Change Today:
    -34.00p
  • 52 Week High: 2,792.00
  • 52 Week Low: 1,637.00
  • Currency: UK Pounds
  • Shares Issued: 66.03m
  • Volume: 9,294
  • Market Cap: £1,137.06m
  • RiskGrade: 128

Geographical - by origin

  30-Jun-2330-Jun-2230-Jun-2130-Jun-2030-Jun-19
Revenue
Asia92.9013%83.3014%101.5018%70.8013%44.209%
Latin America105.6015%94.6016%83.8015%81.8015%81.1017%
North America288.5042%238.5040%214.7037%226.4041%211.8043%
Rest of Europe, Middle East, Russia and Africa109.6016%88.3015%82.1014%78.0014%67.7014%
UK93.1013%88.7015%92.2016%94.4017%83.7017%
Total 689.70100% 593.40100% 574.30100% 551.40100% 488.50100% 
 
Profit Before Tax
Unanalysed39.40100%48.40100%55.80100%46.30100%9.90100%
Total 39.40100% 48.40100% 55.80100% 46.30100% 9.90100% 

Geographical - by origin (turnover)

Product breakdown (turnover)

Product breakdown

  30-Jun-2330-Jun-2230-Jun-2130-Jun-2030-Jun-19
Revenue
Genus ABS318.8046%272.0046%250.1044%237.6043%222.6046%
Genus PIC349.5051%306.6052%315.6055%298.8054%253.7052%
Research and Development21.403%14.802%8.601%15.003%12.202%
Total 689.70100% 593.40100% 574.30100% 551.40100% 488.50100% 
 
Profit Before Tax
Genus ABSn/an/an/an/an/an/a32.50n/a29.90n/a
Genus PICn/an/an/an/an/an/a113.30n/a93.10n/a
Research and Developmentn/an/an/an/an/an/a(64.90)n/a(54.40)n/a
Unanalysed39.40n/a48.40n/a55.80n/a(34.60)n/a(58.70)n/a
Total 39.40n/a 48.40n/a 55.80n/a 46.30n/a 9.90n/a 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: Forecast figures based on normalised accounts.

 

Top of Page